Effects of removing reimbursement restrictions on targeted therapy accessibility for non-small cell lung cancer treatment in Taiwan: an interrupted time series study.

Jason C HsuChen-Fang WeiSzu-Chun Yang

Published in: BMJ open (2019)

The changes in reimbursement policies had a significant impact on the accessibility of targeted therapies for NSCLC treatment. Removing reimbursement restrictions can significantly increase the level and the speed of drug accessibility.

Keyphrases

small cell lung cancer
public health
single cell
cell therapy
emergency department
combination therapy
adverse drug
drug induced